Aguilar Laura K. — SEC Form 4 filings
SEC reporting owner CIK 1873915. 12 Form 4 filings on record with FilingPulse; latest filed 2025-02-25.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-10-03 to 2025-02-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 2 filings — 75,414 shares, $486,476 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
- Largest priced transaction: sale of 26,988 shares @ $6.92 ($186,757) in Candel Therapeutics, Inc., filed 2024-10-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | 10% owner | 12 | — | 6 legs · 75,414 sh · $486,476 | 37 |
Form 4 filings — Aguilar Laura K.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-25 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 10,582 @ $12.02 · Disposition to issuer (D): 10,583 @ $12.02 | EDGAR |
| 2025-02-13 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 31,335 @ $8.61 | EDGAR |
| 2024-12-30 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 50,000 @ $9.01 · Disposition to issuer (D): 50,000 @ $9.01 · Disposition to issuer (D): 50,000 @ $8.85 · Disposition to issuer (D): 50,000 @ $8.85 | EDGAR |
| 2024-12-26 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 100,000 @ $9 · Disposition to issuer (D): 100,000 @ $9 · Disposition to issuer (D): 50,000 @ $8.52 · Disposition to issuer (D): 50,000 @ $8.52 · Disposition to issuer (D): 50,000 @ $8.82 · Disposition to issuer (D): 50,000 @ $8.82 | EDGAR |
| 2024-12-13 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 200,000 @ $8.53 · Disposition to issuer (D): 200,000 @ $8.53 · Disposition to issuer (D): 200,000 @ $10.04 · Disposition to issuer (D): 200,000 @ $10.04 | EDGAR |
| 2024-12-06 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 20,000 @ $4.46 · Disposition to issuer (D): 20,000 @ $4.79 · Disposition to issuer (D): 20,000 @ $5.23 | EDGAR |
| 2024-11-27 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 20,000 @ $4.97 | EDGAR |
| 2024-11-08 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 7,500 @ $5.33 · Disposition to issuer (D): 7,500 @ $5.33 · Disposition to issuer (D): 7,500 @ $5.19 · Disposition to issuer (D): 7,500 @ $5.19 · Disposition to issuer (D): 7,500 @ $4.92 · Disposition to issuer (D): 7,500 @ $4.92 | EDGAR |
| 2024-11-01 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 6,000 @ $5.38 · Disposition to issuer (D): 6,000 @ $5.38 · Disposition to issuer (D): 7,500 @ $5.30 · Disposition to issuer (D): 7,500 @ $5.30 · Disposition to issuer (D): 7,500 @ $5.27 · Disposition to issuer (D): 7,500 @ $5.27 | EDGAR |
| 2024-10-28 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Disposition to issuer (D): 16,427 @ $5.53 · Disposition to issuer (D): 1,194 @ $5.72 · Disposition to issuer (D): 1,597 @ $5.80 · Disposition to issuer (D): 11,711 @ $5.58 | EDGAR |
| 2024-10-15 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Sale (S): 15,000 @ $6.05 · Sale (S): 15,000 @ $6.02 · Sale (S): 10,412 @ $6.03 | EDGAR |
| 2024-10-03 | 4 | Candel Therapeutics, Inc. (CADL) jointly with Aguilar-Cordova Estuardo | Sale (S): 6,214 @ $7.01 · Sale (S): 26,988 @ $6.92 · Sale (S): 1,800 @ $6.85 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1873915 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →